Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ADAM metallopeptidase domain 20 pseudogene is a non-coding, non-functional genomic sequence similar to the ADAM20 gene, which encodes a testis-specific disintegrin and metalloprotease family member involved in fertilization and sperm maturation in humans. As a pseudogene, it does not encode a functional protein and has no known biological or therapeutic role. It is sometimes listed with aliases such as ADAM20P1 or C14orf55. There is a functional gene, ADAM20 (Disintegrin and metalloproteinase domain-containing protein 20), which encodes a metallopeptidase enzyme involved in sperm maturation and fertilization. However, ENSG00000274330 specifically refers to a pseudogene, not this protein-coding gene. In drug discovery and biology, pseudogenes like this are generally not considered direct therapeutic targets.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADAM metallopeptidase domain 20 pseudogene (ADAM20P).